VTGN SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jun 15, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Feb 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jun 17, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

June 2025 ATM

Jun 17, 2025

424B5

Oct 3, 2023

424B5

ATM | Offering amount: $58,800,000 | Amount sold to date: $16,100,000

Aug 8, 2023

424B5

ATM | Offering amount: $10,500,000 | Amount sold to date: $5,601,908 | Float: 7,816,288

Jun 30, 2023

424B5

ATM | Offering amount: $75,000,000

May 14, 2021

424B5

63,000,000 Share of Common Stock-

Dec 18, 2020

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 14, 2024

S-3

SHELF | ATM | Offering amount: $350,000,000.00 EFFECTIVE

Feb 13, 2024

S-3/A

SHARE RESALE REGISTRATION | Shares amount: 12,193,069 | Share price: $0.14 EFFECTIVE

Mar 17, 2023

S-3

SHARE RESALE REGISTRATION | Shares amount: 12,410,100 | Share price: $0.18 EFFECTIVE

Mar 2, 2023

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 17, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 24, 2021

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 31, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 31, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 28, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 16, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 16, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 1, 2024

CORRESP

Form CORRESP - Correspondence

Feb 27, 2024

LETTER

Form UPLOAD - SEC-generated letter

Feb 16, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 22, 2023

CORRESP

Form CORRESP - Correspondence

Mar 17, 2023

LETTER

Form UPLOAD - SEC-generated letter

Mar 9, 2023

VistaGen Therapeutics, Inc. VTGN · SEC Filings